Gregor Werba

5PUBLICATIONS
55CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyPredictive and prognostic markersMechanobiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 11, 2024
Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor.

Paul E Oberstein, Andressa Dias Costa, Emily A Kawaler

|Jul 03, 2023
Author Correction: Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment.

Gregor Werba, Daniel Weissinger, Emily A Kawaler

|Feb 13, 2023
Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment.

Gregor Werba, Daniel Weissinger, Emily A Kawaler

|Jun 12, 2021
The biological underpinnings of therapeutic resistance in pancreatic cancer.

Gregory L Beatty, Gregor Werba, Costas A Lyssiotis

|Aug 23, 2020
Targeting Piezo1 unleashes innate immunity against cancer and infectious disease.

Berk Aykut, Ruonan Chen, Jacqueline I Kim

Pageof 1

Frequent Collaborators

4 joint publications

Diane M Simeone

3 joint publications

Igor Dolgalev

3 joint publications

Paul Oberstein

2 joint publications

Mara H Sherman